 | • レポートコード：TPM-B04282 • 出版社/出版日：Transparency Market Research / 2017年11月 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、硝子体タンポナーデの世界市場について調べ、硝子体タンポナーデの世界規模、市場動向、市場環境、製品別分析、最終用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、バリューチェーン分析、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・硝子体タンポナーデの世界市場動向 ・硝子体タンポナーデの世界市場環境 ・硝子体タンポナーデのバリューチェーン分析 ・硝子体タンポナーデの世界市場規模 ・硝子体タンポナーデの世界市場規模：製品別 ・硝子体タンポナーデの世界市場規模：最終用途別 ・硝子体タンポナーデの世界市場：地域別市場規模・分析 ・硝子体タンポナーデの北米市場規模・予測 ・硝子体タンポナーデのアメリカ市場規模・予測 ・硝子体タンポナーデのヨーロッパ市場規模・予測 ・硝子体タンポナーデのアジア市場規模・予測 ・硝子体タンポナーデの日本市場規模・予測 ・硝子体タンポナーデの中国市場規模・予測 ・硝子体タンポナーデのインド市場規模・予測 ・競争状況・関連企業情報 |
Global Vitreous Tamponades Market: Scope and Methodology
This report on the global vitreous tamponades market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global vitreous tamponades market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global vitreous tamponades market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as rise in incidence of vitreoretinal disorders, increase in geriatric population, and rise in health care infrastructure have been taken into consideration while estimating the market size.
Vitreous Tamponades Market: Segmentation
The vitreous tamponades market has segmented into three categories, namely by product type, by end-user and by region.
Vitreous Tamponades Market: Geographical and Competitive Dynamics
Geographically, the global vitreous tamponades market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, China, Japan, and India.
The report also profiles major players in the vitreous tamponades market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Novartis AG, Valeant Pharmaceuticals International, Inc., Carl Zeiss Meditec AG, Dutch Ophthalmic Research Center B.V., Fluoron GmbH, and AL.CHI.MI.A Srl and others.
Global vitreous tamponades market is segmented as follows:
Global Vitreous Tamponades Market Revenue, by Product Type
Gaseous Tamponades
Liquid Tamponades
Silicone Oil
Perfluorocarbon Liquids
Global Vitreous Tamponades Market Revenue, by End-user
Hospitals
Ophthalmology Clinics
Global Vitreous Tamponades Market Revenue, by Geography
North America
US
Canada
Europe
UK
Germany
France
Rest of Europe
Asia Pacific
China
Japan
India
Rest of Asia Pacific
Rest of the World
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 3 Executive Summary
3.1 Global Vitreous Tamponades Market Snapshot, 2016
3.2 Global Vitreous Tamponades Market: Opportunity Map
Section 4 Market Overview
4.1 Overview
4.2 Global Vitreous Tamponades Market Size (US$ Mn) Forecast, 2015–2025
4.3 Global Vitreous Tamponades Market Outlook
4.5 Global Vitreous Tamponades Market: Porter’s Analysis
4.6 Global Vitreous Tamponades Market: Value Chain Analysis
Section 5 Market Dynamic
5.1 Drivers
5.1.1 Rise in incidence of vitreoretinal disorders
5.1.2 Increase in geriatric population
5.1.3 Rise in health care infrastructure
5.2 Restraints
5.2.1 Complications associated with tamponades
5.2.2 Price competitiveness
5.3 Opportunities
5.3.1 Strong Research and Development Activities to Develop Novel Vitreous Tamponades
5.3.2 Expansion in Emerging Geographies by Key Players
5.4 Key Trends
5.4.1 Investigational Novel Technologies & Products
5.4.2 Use of Combinations as Intraocular Tamponades
Section 6 Global Vitreous Tamponades Market Analysis, by Product
6.1 Introduction
6.2 Global Vitreous Tamponades Market Value Share Analysis, by Product
6.3 Global Vitreous Tamponades Market Value and Volume Forecast By Product
6.3.1 Gaseous Tamponades
6.3.2 Liquid Tamponades
6.3.2.1 Silicone Oil
6.3.2.2 Perfluorocarbon Liquids (PFCL)
6.4 Global Vitreous Tamponades Market Attractiveness Analysis, by Product
Section 7 Global Vitreous Tamponades Market Analysis, by End-user
7.1 Introduction
7.2 Global Vitreous Tamponades Market Value Share Analysis, by End-user
7.3 Global Vitreous Tamponades Market Analysis, by End-user
7.3.1 Hospitals
7.3.2 Ophthalmology Clinics
7.4 Global Vitreous Tamponades Market Attractiveness Analysis, by End-user
Section 8 Global Vitreous Tamponades Market Analysis, by Region
8.1 Global Vitreous Tamponades Market Snapshot, by Country
8.2 Global Vitreous Tamponades Market Value Share Analysis, by Region
8.3 Global Vitreous Tamponades Market Forecast, by Region
8.4 Global Vitreous Tamponades Market Attractiveness Analysis, by Region
8.5 Global Vitreous Tamponades Market: Regional Trends
Section 9 North America Vitreous Tamponades Market Analysis
9.1 Key Findings
9.2 North America Vitreous Tamponades Market Overview
9.3 North America Market Value Share Analysis, by Product
9.4 North America Market Forecast, by Product
9.4.1 Gaseous Tamponades
9.4.2 Liquid Tamponades
9.4.2.1 Silicone Oil
9.4.2.2 Perfluorocarbon Liquids (PFCL)
9.5 North America Market Value Share Analysis, by End-user
9.6 North America Market Forecast, by End-user
9.6.1 Hospitals
9.6.2 Ophthalmology Clinics
9.7 Market Analysis, by Country
9.8 Market Value Share Analysis, by Country
9.9 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
9.9.1 U.S.
9.9.2 Canada
9.1 Market Attractiveness Analysis
9.10.1 By Product
9.10.2 By End-user
9.10.3 By Country
Section 10 Europe Vitreous Tamponades Market Analysis
10.1 Key Findings
10.2 Europe Vitreous Tamponades Market Overview
10.3 Europe Market Value Share Analysis, by Product
10.4 Europe Market Forecast, by Product
10.4.1 Gaseous Tamponades
10.4.2 Liquid Tamponades
10.4.2.1 Silicone Oil
10.4.2.2 Perfluorocarbon Liquids (PFCL)
10.5 Europe Market Value Share Analysis, by End-user
10.6 Europe Market Forecast, by End-user
10.6.1 Hospitals
10.6.2 Ophthalmology Clinics
10.7 Market Analysis, by Country/Sub-region
10.8 Market Value Share Analysis, by Country/Sub-region
10.9 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
10.9.1 Germany
10.9.2 France
10.9.3 U.K.
10.9.4 Rest of Europe
10.10 Market Attractiveness Analysis
10.10.1 By Product
10.10.2 By End-user
10.10.3 By Country/Sub-region
Section 11 Asia Pacific Vitreous Tamponades Market Analysis
11.1 Key Findings
11.2 Asia Pacific Vitreous Tamponades Market Overview
11.3 Asia Pacific Market Value Share Analysis, by Product
11.4 Asia Pacific Market Forecast, by Product
11.4.1 Gaseous Tamponades
11.4.2 Liquid Tamponades
11.4.2.1 Silicone Oil
11.4.2.2 Perfluorocarbon Liquids (PFCL)
11.5 Asia Pacific Market Value Share Analysis, by End-user
11.6 Asia Pacific Market Forecast, by End-user
11.6.1 Hospitals
11.6.2 Ophthalmology Clinics
11.7 Market Analysis, by Country/Sub-region
11.8 Market Value Share Analysis, by Country/Sub-region
11.9 Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2025
11.9.1 Japan
11.9.2 China
11.9.3 India
11.9.4 Rest of Asia Pacific
11.10 Market Attractiveness Analysis
11.10.1 By Product
11.10.2 By End-user
11.10.3 By Country/Sub-region
Section 12 Rest of the World Vitreous Tamponades Market Analysis
12.1 Key Findings
12.2 Rest of the World Vitreous Tamponades Market Overview
12.3 Rest of the World Market Value Share Analysis, by Product
12.4 Rest of the World Market Forecast, by Product
12.4.1 Gaseous Tamponades
12.4.2 Liquid Tamponades
12.4.2.1 Silicone Oil
12.4.2.2 Perfluorocarbon Liquids (PFCL)
12.5 Rest of the World Market Value Share Analysis, by End-user
12.6 Rest of the World Market Forecast, by End-user
12.6.1 Hospitals
12.6.2 Ophthalmology Clinics
12.7 Market Attractiveness Analysis
12.7.1 By Product
12.7.2 By End-user
Section 13 Company Profiles
13.1 Global Vitreous Tamponades Market: Heat Map Analysis
13.2 Competition Matrix
13.3 Company Profiles
13.3.1 Fluoron GmbH
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Strategic Overview
13.3.2 Carl Zeiss Meditec AG
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Overview
13.3.2.3. Product Portfolio
13.3.2.4. SWOT Analysis
13.3.2.5. Strategic Overview
13.3.3 Dutch Ophthalmic Research Center (International) B.V.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Strategic Overview
13.3.4 AL.CHI.MI.A Srl
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Strategic Overview
13.3.5 Arcadophta
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Strategic Overview
13.3.6 Valeant Pharmaceuticals International, Inc.
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Overview
13.3.6.3. Product Portfolio
13.3.6.4. SWOT Analysis
13.3.6.5. Strategic Overview
13.3.7 Novartis AG
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Overview
13.3.7.3. Product Portfolio
13.3.7.4. SWOT Analysis
13.3.7.5. Strategic Overview
Table 01: Global Vitreous Tamponades Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 02: Global Vitreous Tamponades Market Size (US$ Mn) Forecast, by Liquid Tamponades, 2015–2025
Table 03: Global Vitreous Tamponades Market Volume Forecast, by Product, 2015–2025 (No. of Units)
Table 04: Global Vitreous Tamponades Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 05: Global Vitreous Tamponades Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 06: North America Vitreous Tamponades Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 07: North America Vitreous Tamponades Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 08: North America Vitreous Tamponades Market Size (US$ Mn) Forecast, by Liquid Tamponades, 2015–2025
Table 09: North America Vitreous Tamponades Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 10: Europe Vitreous Tamponades Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 11: Europe Vitreous Tamponades Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 12: Europe Vitreous Tamponades Market Size (US$ Mn) Forecast, by Liquid Tamponades, 2015–2025
Table 13: Europe Vitreous Tamponades Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 14: Asia Pacific Vitreous Tamponades Market Size (US$ Mn) Forecast, by Country/Sub -region, 2015–2025
Table 15: Asia Pacific Vitreous Tamponades Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 16: Asia Pacific Vitreous Tamponades Market Size (US$ Mn) Forecast, by Liquid Tamponades, 2015–2025
Table 17: Asia Pacific Vitreous Tamponades Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 18: Rest of the World Vitreous Tamponades Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Rest of the World Vitreous Tamponades Market Size (US$ Mn) Forecast, by Liquid Tamponades, 2015–2025
Table 20: Rest of the World Vitreous Tamponades Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 21: Business Segment: Fluoron GmbH
Table 22: Business Segment: Carl Zeiss Meditec AG
Table 23: Business Segment: Dutch Ophthalmic Research Center (International) B.V.
Table 24: Business Segment: AL.CHI.MI.A Srl
Table 25: Business Segment: Arcadophta
Table 26: Business Segment: Valeant Pharmaceuticals International, Inc.
Table 27: Business Segment: Novartis AG